Indwelling catheter with stable enzyme coating

• US 5,505,713 A
• Filed: 04/01/1994
• Issued: 04/09/1996
• Est. Priority Date: 04/01/1994
• Status: Expired due to Term

• Current Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Original Assignee: Minimed, Inc. (Medtronic Plc)
• Inventors: Van Antwerp, William P.
• Primary Examiner(s): Yasko, John D.
• Assistant Examiner(s): CERMAK, ADAM
• Application Number:
  US08/221,934
• Time in Patent Office: 739 Days
• Field of Search: 604/264, 604/266, 604/890.1, 424/423, 424/424, 424/426, 424/425, 424/430, 424/433
• US Class Current: 604/264
• CPC Class Codes: A61L 29/085 Macromolecular materials
• CPC Class Codes: A61M 25/0017 specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections

Abstract

An improved indwelling catheter adapted for long-term usage includes a stable enzyme coating to prevent occlusion of the catheter lumen. The enzyme coating includes a fibrinolytic and/or lipolytic enzyme incorporated in a catheter coating to resist or control proteolytic degradation, thereby maintaining the enzyme in an active state for dissolving clots and occlusions within the catheter lumen over an extended period of time.

Claims

1. A catheter, comprising:

an elongated tubular element formed from a polymeric material and adapted for patient placement, said tubular element defining a catheter lumen; and

a surface coating applied to said tubular element on at least a portion of the surface thereof, said surface coating including at least one enzyme effective to dissolve occlusions along said catheter lumen, said at least one enzyme comprising a lipolytic enzyme, and means for protecting said enzyme against short-term degradation upon contact with patient body fluids;

said surface coating comprising a membrane having the enzyme cross linked with a serum protein which includes albumin and bonded to said tubular element, and wherein said at least one enzyme comprises phospholipase.

2. The catheter of claim 1 wherein said at least one enzyme comprises a combination of fibrinolytic and lipolytic enzymes.

3. The catheter of claim 1 wherein the enzyme is cross linked with the serum protein by an aldehyde, and further including means for bonding the aldehyde to said tubular element.

4. A catheter, comprising:

an elongated tubular element formed from a polymeric material and adapted for patient placement, said tubular element defining a catheter lumen; and

at least one enzyme on at least a portion of the surface of said tubular element, said enzyme being effective in the presence of patient body fluids to dissolve lipid-based occlusions along said catheter lumen.

5. The catheter of claim 4 further including means for protecting said enzyme against short-term degradation upon contact with patient fluids.

6. The catheter of claim 4 wherein said at least one enzyme comprises phospholipase.

7. A method of applying an enzyme coating to a polymeric catheter, said method comprising the steps of:

cross link bonding at least one lipolytic enzyme which includes phospholipase with a serum protein which includes albumin by means of a cross link agent; and

bonding the cross link agent to at least a portion of the surface of the catheter.

8. The method of claim 7 wherein the cross link agent is an aldehyde.

9. The method of claim 7 wherein said cross link bonding step comprises forming a slurry of the enzyme and serum protein, and contacting the slurry with the cross link agent.

10. The method of claim 7 wherein said step of bonding the cross link agent to the catheter comprises bonding the cross link agent to the catheter by means of a silane compound.